| Product Name | NebuSelect™ Recombinant Human TACI/TNFRSF13B, hFc-tag |
|---|---|
| Catalog Number | NBL-242046 |
| Alias/Synonyms | TACI/TNFRSF13B; CD267; TNFRSF13B; TACI; CVID; CVID2; IGAD2; RYZN; TACI |
| Appearance | see COA |
| Molecule Weight | Ser2-Thr166 |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | O14836-1 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-242046-100ug | 100ug | Inquire | Inquire | |
| NBL-242046-1mg | 1mg | Inquire | Inquire | |
| NBL-242046-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human TACI/TNFRSF13B, hFc-tag
Catalog#:
NBL-242046
Description:
NebuSelect™ Recombinant Human TACI/TNFRSF13B, hFc-tag(Cat#NBL-242046) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Ser2-Thr166.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 45.3 kDa. Due to glycosylation, the protein migrates to 38-40 kDa and 50-55 kDa based on Bis-Tris PAGE result.
Target Name:
TACI/TNFRSF13B; CD267; TNFRSF13B; TACI; CVID; CVID2; IGAD2; RYZN; TACI
Target Information:
Transmembrane activator and calcium-modulating cyclophilin ligand interactor (TACI) is one of the receptors of B cell activating factor of the tumor necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL). TACI is a regulator in the immune responses. TACI inhibits B cell expansion and promotes the differentiation and survival of plasma cells.
Amino Acid Sequence:
Ser2-Thr166
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.